| ★ |  DUPLEX Trial Results: Key Insights in #FSGS | | 71 | Estados Unidos | |
| 10 |  How often should you do an Kidney test? | Pratik Das #shorts #podcast | Podcast with Arijit Chakraborty (Bengali Version) @podcastwitharijitchakraborty | 545.0K | India | 84 |
| 17 |  ¿BROTES REPENTINOS? NUEVO EFFACLAR DUO +M PARCHES PARA IMPERFECCIONES | La Roche Posay México @larocheposaymexico-g9t | 131.1K | México | 83 |
| 20 |  How often is dialysis needed? | Pratik Das #shorts #podcast | Podcast with Arijit Chakraborty (Bengali Version) @podcastwitharijitchakraborty | 102.3K | India | 83 |
| 4 |  Phase 3 VISIONARY: Sibeprenlimab May Preserve #KidneyFunction in IgA Nephropathy | | 981 | Estados Unidos | 86 |
| 11 |  Nefropatía por IgA en adultos Una revisión actualizada | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 690 | — | 84 |
| 7 |  What is the added value of triple therapy in lupus nephritis? | | 438 | — | 84 |
| 12 |  Kidney involvement in Sjögren’s Disease (SjD) | | 401 | — | 84 |
| 5 |  SGLT2 EN ERC Beneficio en todos los estadios | ENSEÑANDO MEDICINA INTERNA @carloswaldomi | 383 | — | 86 |
| 14 |  Where Kidney Biopsy Is Heading Next I #IgA Nephropathy Care | | 366 | Estados Unidos | 84 |
| 13 |  Hemodiálisis incremental como forma de inicio del tratamiento sustitutivo renal | Fundación Renal Española @fundacionrenale | 275 | España | 84 |
| 2 |  Interim Phase 3 VISIONARY Data Show Sibeprenlimab Preserved Kidney Function in IgA Nephropathy | | 233 | Estados Unidos | 87 |
| 3 |  Kidney Compass: VISIONARY 2-Year eGFR Data in IgA Nephropathy | | 199 | Estados Unidos | 86 |
| 15 |  FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 83 |
| 6 |  Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies | | 109 | Estados Unidos | 85 |
| 9 |  Dupilumab Doubled Asthma Remission Odds in Type 2 Asthma: | | 71 | Estados Unidos | 84 |
| 8 |  B-Cell–Targeted Therapies Expand in IgA Nephropathy, With Samir Parikh, MD | | 27 | Estados Unidos | 84 |
| 1 |  Why Patient-Reported Outcomes Matter in #FSGS | | 8 | Estados Unidos | 87 |
| 19 |  Helping Patients with IgAN Navigate Treatment Decisions | | 7 | Estados Unidos | 83 |
| 18 |  Helping Patients with IgAN Navigate Treatment Decisions | | 2 | Estados Unidos | 83 |
| 16 |  30032022 - Unidad 3 - Fisiopatología de adultos - Casos de insuficiencia renal | Nancy Monzon @nancymonzon9782 | 0 | — | 83 |